Reaction
Suspected Transmission Of An Infectious Agent Via Product reporting signals
As of the last recalculation, Suspected Transmission Of An Infectious Agent Via Product appears in 1,218 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is BEVACIZUMAB (PRR 118.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Bevacizumab | 505 | 118.3 | 118.8 |
| Faricimab | 42 | 91.7 | 92.2 |
| Ranibizumab | 56 | 37.7 | 37.8 |
| Methylprednisolone Acetate | 15 | 32.4 | 32.5 |
| Heparin Sodium | 17 | 21.4 | 21.4 |
| Calcium Gluconate | 14 | 20.1 | 20.1 |
| Iohexol | 7 | 14.5 | 14.5 |
| Methadone Hydrochloride | 8 | 12.7 | 12.7 |
| Testosterone Cypionate | 6 | 11.5 | 11.5 |
| Daptomycin | 6 | 11.2 | 11.2 |
| Aflibercept | 20 | 11.1 | 11.1 |
| Tapentadol Hydrochloride | 8 | 4.1 | 4.1 |